Lavin, Mary (Sartorius 202109 President of Sartorius North America) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
Lavino, Francesco Maria (F2G 202104– CEO before Nabriva Therapeutics + Merck (US) + Cubist Pharmaceuticals) |
Chief Executive Officer (CEO) |
F2G (Group) |
United Kingdom (GB) |
LaVoie, Donna L. (LaVoieHealthScience 201812 CEO) |
Chief Executive Officer (CEO) |
LaVoieHealthScience (LHS) |
United States (USA) |
Law, Richard (Exscientia 202101– EVP Strategic Alliances before Evotec + UCSD + LLNL) |
Business Development Manager / Strategy Manager |
Recursion Pharmaceuticals (Group) |
United Kingdom (GB) |
Lawlor, Bridie (FTI Consulting 202004) |
Public Relations Manager / Investor Relations Manager |
FTI Consulting (Group) |
United States (USA) |
Lawrence, David (Valneva 201708– CFO before Acambis + Chiron Vaccines + GSK) |
Chief Financial Officer (CFO) |
Valneva (Group) |
France |
Lawson, Jennifer (Sartorius 201901 Product Manager for Testing at Sartorius Stedim BioOutsource) |
Product Manager (personnel) |
Sartorius (Group) |
United Kingdom (GB) |
Lawton, Vincent (Merck (US) former Managing Director of Merck Sharp & Dohme UK + VP MSD Europe) |
Managing Director |
Merck (US) (MSD) (Group) |
United Kingdom (GB) |
Laxhuber, Ludwig A. |
n. a. |
Infineon (Group) |
Germany |
Layton, David (Partners Group 2024 CEO) |
Chief Executive Officer (CEO) |
Partners Group (Group) |
Switzerland |
Lazar, David E. (OpGen 202403– CEO + Private Investor) |
Chief Executive Officer (CEO) |
OpGen (Group) |
United States (USA) |
Lazarus, Tadd S. (Qiagen 201301– CMO based in US before at Gen-Probe CMO) |
Chief Medical Officer (CMO) |
Qiagen (Group) |
United States (USA) |
Le Brun, Stéphane(Innopsys 201303 CEO + Financial Director) |
Chief Executive Officer (CEO) |
Innopsys (Group) |
France |
Le Meunier, Ludovic (Alcen 202402 CEO of Theryq) |
Chief Executive Officer (CEO) |
Alcen (Group) |
France |
Leanderson, Tomas (Active Biotech 2008–201706 CEO joined 1999 LEFT 7/17) |
Chief Executive Officer (CEO) |
Active Biotech (Group) |
Sweden |
Lebeaut, Alexandre (Ipsen 201811 EVP RnD + CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Ipsen (Group) |
France |
Leber, Alexander (iAtros GmbH 202003 Managing Director + Co-Founder) |
Managing Director |
iAtros GmbH |
Germany |
Leder, Ethan D. (Precision for Medicine 2012– Executive Chairman + Co-Founder before United BioSource 200312 founder) |
Company Founder |
Precision Medicine Group (Group) |
United States (USA) |
Leder, Günther (Culavis 2007 Managing Director) |
Chief Executive Officer (CEO) |
Culavis GmbH |
Germany |
Ledig, Matthias |
n. a. |
Capgemini (Group) |
Germany |
Lee, Bill (Gilead Sciences 201806 EVP Research) |
Research & Development Manager |
Gilead Sciences (Group) |
United States (USA) |
Lee, Carol (Affect Inc 201412) |
Public Relations Manager / Investor Relations Manager |
Affect Inc. |
United States (USA) |
Lee, Chan (BeiGene 202207– General Counsel before Sanofi + Pfizer) |
General Counsel / Chief Legal Officer (CLO) |
BeOne Medicines (Group) (formerly BeiGene) |
China |
Lee, Denise (Metronomia Clinical Research GmbH 202007– Managing Director before Allergy Therapeutics) |
Managing Director |
Metronomia Clinical Research GmbH |
Germany |
Lee, Jung Hee (Yuhan 201907 CEO of Yuhan Corp) |
Chief Executive Officer (CEO) |
Yuhan Corporation (Yu Han) (000100:KS) |
Korea, Republic of |
Lee, Kwang-Hyung (KAIST 202405 President) |
President/Director/Head of Research Organisation/Unit |
KAIST (Korea Advance Institute of Science and Technology) |
Korea, Republic of |
Lee, Michael (Syngenta 201809 Director at Syngenta Ventures) |
Investment Manager |
Syngenta (Group) |
|
Lee, Mike (Redmile Group 201801 Portfolio Manager + Co-Founder) |
Investment Manager |
Redmile Group LLC |
United States (USA) |
Lee, Milton (Ballista Inc 201007 Managing Director) |
Managing Director |
Stratec (Group) |
United States (USA) |
Lee, Rosy (Thermo Fisher 201510 VP + General Manager of Human Identification) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
Lee, Seong-Wook (Rznomics 202010 CEO + Founder + Prof at Donkook Univ) |
Chief Executive Officer (CEO) |
Rznomics Inc. (KR) |
Korea, Republic of |
Lee, Sung (MorphoSys 202102–202303 CFO before Sangamo + Gilead Sciences LEFT 3/23) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Germany |
Lee, Young-Ae (Charité 201402– Professor for molecular pediatric allergology) |
Professor |
Humboldt University Berlin |
Germany |
Lee-Chin, Michael (Portland Holdings 202106 Chairman + Founder) |
Board member, executive |
Portland Holdings |
|
Leemhuis, Michel (Kadans Science Partner 202011 CEO) |
Chief Executive Officer (CEO) |
Axa (Group) |
Netherlands |
Leenders, Frank (Celares GmbH 201507 Managing Director of Operations + Co-Founder) |
Managing Director |
Biosynth (since 9/22) (Group) |
Germany |
Lees, Andrew (Fina Biosolutions 202410 CEO + Founder) |
Chief Executive Officer (CEO) |
Fina Biosolutions LLC (FinaBio) |
United States (USA) |
Leewe, Jörn (Novumed 2003–201004– Managing Director + Founder before Boston Consulting Munich) |
Managing Director |
Novumed / Effimed (Group) |
Germany |
Legg, Ben (Centogene 202004 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Centogene (Group) |
Germany |
Leggewie, Christian (Evocatal 201306 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Advanced Enzyme Technologies (Advanced Enzymes) (Group) |
Germany |
Legorreta, Pablo (Royalty Pharma 202006 CEO + Founder) |
Chief Executive Officer (CEO) |
Royalty Pharma (Group) |
United States (USA) |
Legrain, Pierre (HUPO 201109 Vice President HUPO) |
HUPO (Human Proteome Organisation) |
HUPO (Human Proteome Organisation) |
Canada |
Lehmann, Caroline (LBBW 202407 Investment Manager at LBBW Venture Capital GmbH) |
Investment Manager |
LBBW (Group) |
Germany |
Lehmann, Heike (Insilico Biotechnology 201206 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Yokogawa (Group) |
Germany |
Lehmann, Holger (Merck (US) 201502 Head Drug Discovery at MSD Animal Health) |
Research & Development Manager |
Merck (US) (MSD) (Group) |
|
Lehmann, Jonas (Venneos 2014– Co-Founder) |
Company Founder |
Venneos GmbH |
Germany |
Lehmann, Klaus (High-Tech Gründerfonds 201501) |
n. a. |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Lehmann, Marc (SmartDyeLivery GmbH 20602 Managing Director) |
Managing Director |
SmartDyeLivery GmbH |
Germany |
Lehmann, Martin (Metabolomic Discoveries 201102 Senior Scientist) |
Researcher (industry) |
Metabolon (Group) |
Germany |
Lehmann, Rainer (Novonesis 202401 CFO before Sartorius 201703–202310 CFO before SVP Business Processes Unit ) |
Chief Financial Officer (CFO) |
Novonesis (Group) |
Denmark |
Lehmann, Thomas |
n. a. |
Brandenburg (govt region) |
Germany |
Lehmann, Wolf Dieter (Helmholtz 201007 Professor DKFZ GPCF Mass Spectrometry Group) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Lehn, Jean-Marie (Therascope founder) |
Company Founder |
Amgen (Group) |
Germany |
Lehner, Oliver (AstraZeneca 201809 VP Business Development + Partnering at Definiens AG) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
Germany |
Lehrach, Hans (Max Planck Professor MPI for Molecular Genetics) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
Lehrke, Ingo (Algiax Pharmaceuticals 2019– CEO + Tubulis 202007 CBO) |
Chief Executive Officer (CEO) |
Algiax Pharmaceuticals GmbH |
Germany |
Lehtonen, Tommi (Hedera Dx 202209 CEO + +Co-Founder before Blueprint Genetics 201707 CEO) |
Chief Executive Officer (CEO) |
Hedera Dx S.A. |
Switzerland |
Lehuu, Bertrand (BioXell 200703– CBO before 25y pharma industry incl Global Licensing Director at Roche in Basel) |
Chief Business Officer (CBO) |
Cosmo Pharmaceuticals (Group) |
Italy |
Leibfritz, Dieter (Univ Bremen 200906 Prof Dept Biology/Chemistry Chair for Instrumental Analytics) |
Professor |
University of Bremen |
Germany |
Leibinger, Peter (Germany (govt) 202211 Chair of Supervisory Board at Sprind GmbH) |
Supervisory Board Member |
Germany (govt) |
Germany |
Leibinger, Wolfgang (Qiagen –200702– Global Business Director Automated Systems) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
Leiden, Jeffrey M. (Vertex 20212– CEO before Clarus Ventures + Abbott) |
Chief Executive Officer (CEO) |
Abbott (Group) |
United States (USA) |
Leidenberger, Freimut |
n. a. |
BioAgency AG |
Germany |
Leigh, Darin (Mainz Biomed 202204– CCO before CDR Health + Metabolon + Asuragen + Luminex + Abbott) |
Chief Commercial Officer (CCO) |
Mainz Biomed N.V. (Nasdaq: MYNZ) |
Germany |
Leikert, Christian (Carma Fund 202206– General Partner before Creathor Ventures + Future Capital) |
Partner (venture partner) |
Carma Fund (Group) |
Germany |
Leimer, Axel (AMSilk 201103 Managing Director) |
Managing Director |
AMSilk GmbH |
Germany |
Leimer, Axel (Leimer Industry Consulting 200603) |
n. a. |
Hessen (Hesse) (govt region) |
Germany |
Leiminger, Roland (Biocrates 20130923 Sr Medical Advisor Diagnostics) |
Sales Manager / Marketing Manager |
Biocrates (Group) |
Austria |
Lein, Jens (KWS Saat 201412) |
n. a. |
KWS Saat (Group) |
Germany |
Leino, Lasse (DelSiTech 201609 CEO) |
Chief Executive Officer (CEO) |
DelSiTech Ltd. (FI) |
Finland |
Leisner, Christian (CDR-Life 202204 CEO) |
Chief Executive Officer (CEO) |
CDR-Life AG |
Switzerland |
Leiss, Florian (Ultivue 202211 VP Product Strategy + Corp Development formerly Definiens) |
Public Relations Manager / Investor Relations Manager |
Ultivue Inc. |
Germany |
Leistner, Hermann (Stratec Biomedical Systems –201103 CEO + Founder retired 3/11) |
Chief Executive Officer (CEO) |
Stratec (Group) |
Germany |
Leitner, Michael (Public Health PR 201009 Managing Director) |
Managing Director |
Public Health PR-Projektgesellschaft mbH |
Austria |
Leitzke, Achim (Macherey-Nagel 201902 General Manager Sales + Marketing) |
Sales Manager / Marketing Manager |
Macherey-Nagel GmbH & Co KG |
Germany |
Lelieveld, Paul (Stichting Participatie Atriva 201702 Director + Meneldor 201806 Co-Founder) |
Investment Manager |
Stichting Participatie Atriva (Foundation Participation Atriva) |
Netherlands |
Lelouche, Erick (Boehringer 201804 President of Boehringer Ingelheim Animal Health France) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
France |
Lemaître, Marc (Solvay 201108 Executive Board Director) |
Board member, executive |
Solvay (Group) |
Germany |
Lemarie, Cedric (Agilent 200809) |
n. a. |
Agilent (Group) |
Germany |
Lemere, Cynthia (Brigham & Women’s Hospital + Harvard Medical School 201011 Assoc Prof) |
Professor |
Partners HealthCare System (Group) |
United States (USA) |
Lemke, Andreas (Mediaire 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Mediaire GmbH |
Germany |
Lemmen, Christian (BioSolveIT GmbH 201110 Managing Director) |
Managing Director |
BioSolveIT GmbH |
Germany |
Lemmens, Katrien (SGS 201611– Medical Director Early Phase Clinical Trials at SGS Clinical Research) |
Managing Director |
SGS (Group) |
Belgium |
Lemus, Dave (Proteros 201712– COO + CFO before Medigene + Sigma-Tau Pharmaceuticals + MorphoSys) |
Chief Operating Officer (COO) |
Proteros (Group) |
Germany |
Lenarz, Thomas (MHH 201009 Professor + Clinical Director) |
Professor |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
Lendi, Pietro (Bruker 201104 VP RnD Bruker BioSpin CH) |
Research & Development Manager |
Bruker (Group) |
Switzerland |
Lengauer, Christoph (Third Rock Ventures 201807 Venture Partner + Germany (govt) 201601 CEO of GALS) |
business program (governmental) |
Third Rock Ventures LLC |
United States (USA) |
Lengauer, Th. |
n. a. |
Fraunhofer (Group) |
Germany |
Lenggenhager, René (Bruker Corp 201511– President of BioSpin Group before Mettler Toledo since 2000 before Siemens) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
Lenk, Norbert (Nano Analytik GmbH 201004– Managing Director) |
Managing Director |
Nano Analytik GmbH |
Germany |
Lenke, Rolf (Dechema) |
n. a. |
DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e. V. |
Germany |
Lennon, Dave (Novartis/AveXis 201904 President) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
United States (USA) |
Lensky, Stephan (EpimAb Biotherapeutics 201610 COO/CBO) |
Chief Operating Officer (COO) |
EpimAb Biotherapeutics (Group) |
China |
Lenz, Christof (Hemovent GmbH 201602 Managing Director (CEO) + Co-Founder) |
Managing Director |
Hemovent GmbH |
Germany |
Lenz, Ruxandra (SphingoTec 202111 Senior Manager Marketing + Communications before Centogene) |
Public Relations Manager / Investor Relations Manager |
SphingoTec (Group) |
Germany |
Leo, Chandra P. (HBM 201810) |
Investment Manager |
HBM (Group) |
Switzerland |
Leo, Giovanni (EFI Lake Geneva Ventures I 202306 Partner + EBAMed 202306 Co-Founder + Chair) |
Partner (venture partner) |
|
|
León, Lucas (Akvolution GmbH 201608 CFO + Founder) |
Chief Financial Officer (CFO) |
Akvolution GmbH (Akvola Technologies) |
Germany |
Leonard, John M. (Intellia Therapeutics 201801– CEO joined 2014 before 22 years at AbbVie + Abbott) |
Chief Executive Officer (CEO) |
Intellia Therapeutics Inc. (Nasdaq: NTLA) |
United States (USA) |
Leonard, Keith (Kythera 201101 CEO + Co-founder before SVP + General Manager Amgen Europe) |
Chief Executive Officer (CEO) |
Allergan (Group) |
United States (USA) |